
Innovative Treatment for Glioblastoma in Germany: Dendritic Cell Therapy for Cancer
Standard therapy for glioblastoma includes surgical removal of the tumor in combination with chemotherapy or radiation therapy. With standard treatment of glioblastoma, the average life expectancy after diagnosis is 15-17 months, and the 5-year survival rate does not exceed 5-10%. Supplementing the standard protocol with the dendritic cell vaccine is the most promising approach, the effectiveness of which exceeds all therapies currently used in neurooncology. According to the results of clinical trials, 60% of patients who received immunotherapy treatment live longer than the average expected…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.